Theravance Biopharma and Viatris

Theravance Biopharma's focus is to deliver Medicines that Make a Difference®. Leveraging decades of expertise has led to the development of FDA-approved YUPELRI® (revefenacin) indicated for the maintenance treatment of patients with COPD.